Corey Casper is the Chief Executive Officer at the Infectious Disease Research Institute (IDRI). At IDRI, Dr. Casper oversees a portfolio of vaccines, therapeutics, and diagnostics that provide comprehensive solutions to global health problems. These include immune-enhancing adjuvant formulations that enable strong, safe and durable vaccines, a novel RNA vaccine platform for the prevention of pandemic / emerging viruses, and products for the treatment and prevention of cancer in low- and middle-income countries.
Dr. Casper received his medical degree from Cornell University, and completed Residency in Internal Medicine at the University of California – San Francisco and Fellowship in Infectious Disease at the University of Washington, where he also earned a Masters of Public Health. His research focuses on the relationship between infectious diseases, immunity and cancer. He has authored more than 125 peer-reviewed publications, and has received funding as the Principal Investigator of more than 100 million dollars in NIH and industry-sponsored studies. Key contributions to science include the development and deployment of diagnostic assays for tumor viruses, design and execution of Phase 1 and Phase 2 vaccine trials, leadership of multi-phased international immunotherapy clinical trials from conception to publication culminating in FDA licensure, epidemiologic and cost effectiveness analyses, and translational studies of the virologic and immunologic basis of infectious diseases and cancer.
Dr. Casper is also a committed educator and clinician. He is a Clinical Professor of Medicine and Global Health at the University of Washington (where he is the Associate Director of the Center for AIDS Research) and an Affiliate Professor in the Vaccine and Infectious Disease Division at the Fred Hutchinson Cancer Research Center (where he served as Associate Cancer Center Director and Founding Head of the Global Oncology Program). Dr Casper cares for patients with infectious diseases and cancer at the Seattle Cancer Care Alliance and the University of Washington Medical Center.